Skip to main content
. 2018 Jan 15;8:744. doi: 10.3389/fneur.2017.00744

Table 2.

Characteristics of 20 animal studies (21 experiments).

Reference Animal model N Injury type Control group(s) Intervention Via Initiation of intervention Other doses Follow-up
Abdel-Baki et al. (37) Sprague–Dawley rats, 250–300 g NR CCI, moderate
  1. Sham injury + NS

  2. Injury and NS

NAC 150 mg/kg IP 1 h Once daily on days 1 and 2 1 week

Chen et al. (38) Wistar rats, 250–300 g 51 Weight drop, moderate
  1. Sham injury + NS

  2. Injury and saline

NAC 150 mg/kg IP 15 min Once daily on days 1, 2, and 3 3 days

Du et al. (39) Long Evans pigmented rats, 360–400 g 74 Blast exposure, 14psi, mild Normal control NAC 300 mg/kg
HPN-07 98.5%
IP 1 h Twice daily on days 1 and 2 7, 14, and 21 days

Eakin et al. (40) 1. Sprague–Dawley rats. 350–400 g 26 FPI, 1.8–1.9 atm, mild
  1. Sham

  2. Injury

NAC 50 mg/kg IP 30 min Once daily on days 1, 2 and 3 14 days

Eakin et al. (40) ICR mice, 30–40 g 32 Weight drop, ~30 g, mild
  1. Sham vehicle (DMSO)

  2. Sham + drug

  3. Injury

NAC 100 mg/kg IP 1 h NR 7 days
Topiramate 30 mg/kg 30 days

Ellis et al. (41) Cats 17 FPI, mild Injury 1. Pre-TBI 326 mg/kg
2. Post-TBI 163 mg/kg
IP 30 min NR 80 min

Ewert et al. (42) Long Evans pigmented rats, 360–400 g 48 Blast exposure, ~ 14psi, mild Injury NAC 300 mg/kg
HPN-07 300 g/kg
IP 1 h Twice daily for 2 days 3 and 24 h
7 days and 21days

Gunther et al. (43) Sprague–Dawley rats, 250–400 g 24 Penetrating ballistic like, moderate
  1. Injury

  2. Sham surgery

NACA 300 mg/kg IP 2 min 24 h survivors 300 mg/kg 2 and 24 h

Haber et al. (44) Sprague–Dawley rats, 250–300 g NR CCI, moderate
  1. Sham + NS

  2. Injury + NS

  3. Minocycline 45 mg/kg

1. NAC 150 mg/kg
2. NAC 150 mg/kg + minocycline 45 mg/kg
IP 1 h Once daily on days 1 and 2 31 days

Hicdonmez et al. (45) Sprague–Dawley rats, 280–320 g 36 Weight drop ~0.5J, moderate
  • (1)

    No injury

  • (2)

    Injury

NAC 150 mg/kg IP 15 min NR 2 and 12 h

Kawoos et al. (46) Sprague–Dawley rats, 300–350 g 88 Blast overpressure, mild Placebo (6 groups based on repetitive BOP) NACA 500 mg/kg in each group, for 6 different groups IP 2 h in 6 groups and 15 min prior TBI in 1 group 1 group: NACA at 2 + 4 h post TBI 7 days

Naziroglu et al. (47) Sprague–Dawley rats, 330 ± 20g 36 Weight drop contusion, moderate
  1. No injury

  2. TBI

  3. TBI + Se

NAC 150 mg/kg Oral 1 h Once at 24 h, 48 h, and 72 h 3 days

Pandya et al. (48) Sprague–Dawley rats, 300–350 g 51 CCI, moderate TBI + vehicle 1. NAC 150 mg
2. NACA 150 mg/kg and 18.5 mg/kg/h
IP 5–30 min 18.5 mg/kg/h NAC, NACA or vehicle 25 h to 15 days

Senol et al. (20) Sprague–Dawley rats, 300–340 g 36 Weight drop, moderate
  1. No injury

  2. TBI

  3. TBI + Se

NAC 150 mg/kg Oral 1 h Once at 24 h, 48 h, and 72 h 4 weeks

Silva et al. (49) Wistar rats,270–300 g NR FPI, moderate Injury + NS NAC 100 mg/kg Oral Immediately Once daily for 5 weeks 5 weeks

Thomale et al. (50) Sprague–Dawley rats, 300–350 g 48 CCI, moderate
  1. Injury + NS

NAC 163 mg/kg IP Immediately 2 and 4 h 24 h

Thomale et al. (51) Sprague–Dawley rats, 300–350 g 62 CCI, moderate
  1. Injury + NS

NAC 163 mg/kg IP 15 min 2 and 4 h 24 h

Xiong et al. (52) Sprague–Dawley rats, 200–350 g NR CCI, moderate
  1. Sham

  2. Injury

  3. Vehicle

NAC 163 mg/kg IP 4 groups:
  1. 5 min before

  2. 30 min after

  3. 1 h after

  4. 2 h after

2 groups post TBI:
  • 1.

    5 m and 15 m

  • 1.

    5 m and 30 m

12 hours
14 days

Xiong et al. (53) Sprague–Dawley rats, 200–350 g NR CCI, moderate
  1. Sham

  2. Injury

NAC 163 mg/kg IP 30 min NR 1, 4 and
12 h
1 and
14 days

Yiand Hazell (54) Sprague–Dawley rats, 200–350 g 64 FPI, moderate
  1. Sham + NS

  2. Injury + NS

NAC 163 mg/kg IP 5 min 6 and 24 h 6 and 24 h
Yi et al. (55) Sprague–Dawley rats, 200–350 g 66 FPI, moderate
  1. Sham + NS

  2. Injury + NS

NAC 163 mg/kg IP 5 min NR 6 and 24 h3 and 7 days

atm, atmospheric pressure; BOP, blast overpressure; CCI, controlled cortical impact; DMSO, dimethyl sulfoxide; FPI, fluid percussion injury; HPN, 2,4-disulfonyl α-phenyl tertiary butyl nitrone; ICR, imprinting control region; IP, intra-peritoneal; NACA, n-acetylcysteine amide; NAC, n-acetylcysteine; NR, not reported; NS, normal saline; PSI, pounds per square inch; Se, selenium; TBI, traumatic brain injury.